Prosecution Insights
Last updated: October 04, 2026

Opus Life Sciences LLC

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Opus Life Sciences LLC has 1 pending office action in the Chemistry & Materials technology area. This matter is situated within a distinct art unit, indicating a focused effort in a specific branch of chemical or material science. The prosecution involves 1 distinct examiner, which simplifies the interaction between the applicant and the patent office by providing a single point of contact. This focused approach is typical for portfolios with limited active filings, where the goal is to resolve the outstanding matter efficiently.

The busiest examiner, ROMANOWSKI, MICHAEL C, is currently handling the pending office action. This represents the total volume of pending actions for Opus Life Sciences LLC, making this examiner the primary official responsible for the portfolio's current progress. The outcome of the prosecution will depend on the practitioner's ability to address the specific concerns of ROMANOWSKI, MICHAEL C within the 1 distinct art unit. Practitioners should tailor their arguments to the specific preferences and past history of this official within the Chemistry & Materials field.

Because there is only 1 pending office action, the prosecution strategy is highly concentrated. There are no other active matters to create conflicting priorities or require different technical arguments. The focus is entirely on the Chemistry & Materials sector as interpreted by the distinct examiner assigned to the case, allowing for a precise and targeted response. Success in this matter will secure the company's position in the chemical sciences sector and provide a foundation for future intellectual property growth.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROMANOWSKI, MICHAEL C 1 53.2% +62.4%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18281543 FLUORESCEIN FORMULATIONS AND KITS ROMANOWSKI, MICHAEL C —

Top Art Units

Art UnitApps
1782 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18281543 FLUORESCEIN FORMULATIONS AND KITS ROMANOWSKI, MICHAEL C 1782 §103§112DP Non-Final OA — Pending Sep 11, 2023

Managing Opus Life Sciences LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month